Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
4DMedical Ltd ( (AU:4DX) ) has shared an update.
4DMedical Limited has applied to the ASX for quotation of an additional 1,206,912 ordinary fully paid shares, issued on 10 April and 17 April 2026, under its ticker 4DX. The new securities arise from the exercise or conversion of existing options or other convertible instruments, modestly expanding the company’s listed share base and providing incremental capital flexibility for its ongoing operations.
The issuance and quotation of these new shares slightly increase the company’s free float and may enhance trading liquidity for investors. While the transaction is routine in nature, it reflects ongoing utilisation of incentive or financing instruments and signals continued engagement by holders of options and convertible securities in 4DMedical’s equity.
The most recent analyst rating on (AU:4DX) stock is a Sell with a A$3.00 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd is an Australian-listed medical technology company focused on respiratory imaging solutions. It develops software and imaging platforms designed to improve the diagnosis and management of lung and respiratory conditions, primarily serving healthcare providers and institutions that require advanced pulmonary function assessment.
Average Trading Volume: 7,474,827
Technical Sentiment Signal: Buy
Current Market Cap: A$3.73B
Find detailed analytics on 4DX stock on TipRanks’ Stock Analysis page.